Efficacy of Erector Spinae Plane Block for Postoperative Analgesia in Adult Patients Undergoing Thoracoscopy

Pain, Postoperative Clinical Trial

Official title:

Efficacy of Erector Spinae Plane Block for Postoperative Analgesia in Adult Patients Undergoing Thoracoscopy

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT03454191
• Other study ID #: CER 2017-01772
• Status: Recruiting
• Phase: N/A
• Start date: February 1, 2018
• Est. completion date: February 1, 2024

Study information

• Verified date: March 2022
• Source: Centre Hospitalier Universitaire Vaudois
• Contact: Eric Albrecht, PD- MER
• Phone: +41 79 556 63 41
• Email: eric.albrecht[@]chuv.ch
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The erector spinae plane block has been recently described as an effective analgesic postoperative pain treatment in case reports. It consists of injecting local anaesthetics below the erector spinae muscle, at the level of the transverse processes, in order to anaesthetize the thoracic roots coming out from the spinal cord. However, the analgesic efficacy has never been demonstrated in a randomized controlled trial. Therefore, the objective of this study is to investigate the analgesic benefit of this block on patients scheduled for thoracoscopy.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 50
• Est. completion date: February 1, 2024
• Est. primary completion date: February 1, 2024
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patients scheduled for thoracoscopy

• physical status I-III

Exclusion Criteria:

• allergy to local anaesthetics

• other contraindications to peripheral nerve blocks

• patients suffering from chronic pain condition

Related Conditions & MeSH terms

• Pain, Postoperative

Intervention

Procedure:
• Erector spinae plane block
Injection of local anaesthetics below the erector spinae muscle after induction of anaesthesia
• No injection
No injection

Locations

Country	Name	City	State
Switzerland	Department of Anesthesia, Centre Hospitalier Universitaire Vaudois and University of Lausanne	Lausanne	Vaud

Sponsors (1)

Lead Sponsor	Collaborator
Eric Albrecht

Country where clinical trial is conducted

Switzerland, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	IV morphine consumption	mg	24 postoperative hours
Secondary	IV morphine consumption	mg	2 postoperative hours
Secondary	IV morphine consumption	mg	48 postoperative hours
Secondary	Pain scores	Visual analog scale, 0-10	2, 24, 24 postoperative hours
Secondary	Chronic pain scores	Visual analog scale, 0-10	3 and 6 postoperative months
Secondary	Forced vital capacity	L	24 and 48 postoperative hours